Stocks and Investing Stocks and Investing
Mon, February 20, 2023
Fri, February 17, 2023

Tiago Fauth Reiterated (ASND) at Buy and Held Target at $130 on, Feb 17th, 2023


Published on 2024-10-28 01:44:46 - WOPRAI, Tiago Fauth
  Print publication without navigation


Tiago Fauth of Credit Suisse, Reiterated "Ascendis Pharma A/S" (ASND) at Buy and Held Target at $130 on, Feb 17th, 2023.

Tiago has made no other calls on ASND in the last 4 months.



There are 5 other peers that have a rating on ASND. Out of the 5 peers that are also analyzing ASND, 0 agree with Tiago's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Tiago


  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $163 on, Tuesday, January 17th, 2023
  • Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $177 on, Tuesday, January 3rd, 2023
  • Andreas Argyrides of "Wedbush" Maintained at Buy with Increased Target to $164 on, Monday, November 14th, 2022
  • David Lebowitz of "Citigroup" Maintained at Strong Buy with Increased Target to $163 on, Thursday, November 3rd, 2022
  • Paul Choi of "Goldman Sachs" Initiated at Strong Buy and Held Target at $174 on, Thursday, October 20th, 2022
Contributing Sources